GSK Signs GMP Consent Decree For Cidra Plant But Avoids Disgorgement Fee

Good manufacturing practices compliance efforts under GlaxoSmithKline's consent decree with FDA are likely to cost the company significantly less than Schering-Plough's 2002 agreement with the agency